Pay in 4 interest-free payments of $5.10 Learn more
Ships within 48 hours · Estimated delivery Oct 19 - Oct 24
Patients should: Weigh themselves once weekly at the same time and under consistent conditions Record measurements in a diary or app to identify trends Aim for gradual weight loss (NHS advises 0.51 kg per week is generally safe and sustainable) Understand that response to GLP-1 therapy varies between individuals Report unexpected rapid weight loss or gain to their healthcare provider It is important to recognise that weight loss may plateau after several months, and this does not necessarily indicate treatment failure
Key takeaways Liraglutide is the active ingredient in the brand-name GLP-1 medications Saxenda and Victoza, while semaglutide is the active ingredient in Ozempic, Wegovy, and Rybelsus
The priority is to keep you feeling well enough to maintain your daily life and healthy habits
Anyone participating in a trial should follow the schedule set by their clinical team precisely, including guidance on what to do if a dose is missed, rather than making independent decisions about timing or frequency
Adjustments in dosing and monitoring are important during the transition
